Assam raises coronavirus alert after Bhutan reports first case; American who tested positive had spent week in state

-

Fear gripped Assam as Bhutan announced its first case of novel coronavirus on Friday. An elderly US tourist who tested positive for COVID-19 was traced to have spent at least a week in Assam as part of his India tour from 21 February to 1 March.

He is travelling with his 59-year-old partner, and had taken a flight to Bhutan from Guwahati on 2 March. Among the ten other passengers on board the Drukair flight, eight are Indian nationals.

"At the Paro International Airport, the patient’s health declaration form was assessed. He had indicated ‘negative’ against all conditions. He did not have a sign of fever," read an official statement by the Bhutan government.

coronavirus

Representational image. AP

“The patient suffers from chronic hypertension and is on medication. However, even at that time, he did not have any flu symptoms,” the statement further read.

The 76-year-old tourist was tested positive after being kept under observation at a flu clinic designated for COVID-19 patients. It is unclear where the US patient contracted the illness, but he is said to have travelled to Mumbai, Kolkata and Assam before visiting Bhutan.

While the Bhutan government has traced over 90 contacts through the patient’s itinerary that included people he associated with along the way, Assam health minister Himanta Biswa Sarma said the state government will trace the places the US tourist had visited.

The American tourist had gone on a weeklong Brahmaputra river cruise on board the MV Mahabaahu, which is run by a private firm in collaboration with the Assam Tourism Development Corporation (ATDC). The cruise ship has a capacity of about 50 people, and was carrying a small group of tourists on 24 February from Guwahati. There were three other passengers on board the cruise ship, in which the unnamed tourist travelled for seven days, embarking and disembarking at various places during the journey.

"All four of them were US nationals, and two of them have returned to their country. The passenger who has tested positive had not shown any symptoms while being on board — he had no cough or cold. Therefore, the chances of him infecting anybody is remote. Once the passengers disembarked in Guwahati, the (cruise) ship was fumigated as per normal routine procedure before a new group boarded it,” said Sanjay Basu, chairman, Adventure Resort and Cruises.

“Neither the crew members nor passengers have shown any symptoms so far. They are all in good health. We have a paramedic on board the (cruise) ship. Six days have passed, and tomorrow, a medical team from Assam will come for check-up,” added Basu.

The MV Mahabaahu has been sailing since last Sunday with 22 passengers from different countries and 35 crew members on board.

The Guwahati to Jorhat upstream cruise ship covers seven nights and eight days, the first stop being Kamakhya Temple. Tourists are also taken to Umananda or the ‘Peacock Island’ as part of the package. They also get the opportunity to visit Kaziranga National Park, a tea-estate, a tribal village, places of historical interest and the culturally rich river island of Majuli.

Another cruise liner by a Guwahati-based company, Jungle Travels India Private Limited (JTI), remains operational from Guwahati to Silghat near Tezpur. Tourists in this cruise vessel are also taken to Kamakhya Temple and the Kaziranga National park among other sites. Tourism officials could not be reached at the time of filing this report.

Meanwhile, denying any laxity in screening passengers, the Director of Guwahati’s Lokapriya Gopinath Bordoloi International Airport, Ramesh Kumar said that members of the Airport Health Organization (APHO) have been on the job of identifying all passengers who travelled in the Drukair flight with the US tourist.

Thirty-one cases of COVID-19 have been confirmed in India so far, with the latest being reported in Delhi.

 

 



from Firstpost India Latest News https://ift.tt/2PTTGLa
Karishma Hasnat

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more